Back to Top

Postmenopausal Osteoporosis

Get Help with Your Treatment

Apply Online or call 1-866-316-7263

 

Program Status

Open - We are accepting applications for new and renewal patients. If your application for assistance is approved you can begin receiving funding immediately.  

 

 

 

 

Maximum Award Level

$750 per year.

Eligibility Criteria

  1. The patient must be getting treatment for the disease named in the assistance program to which he or she is applying.
  2. The patient must have Medicare health insurance that covers his or her qualifying medication or product. 
  3. The patient’s medication or product must be listed on PAN’s list of covered medications.
  4. The patient’s income must fall at or below 400% of the Federal Poverty Level.
  5. The patient must reside and receive treatment in the United States or U.S. territories. (U.S. citizenship is not a requirement.)
list icon
See the list of medications covered in this program
View List  
  • Actonel (risedronate)
  • Alora (estradiol)
  • Atelvia (risedronate)
  • Binosto (alendronate)
  • Boniva (ibandronate)
  • Cenestin (estrogen)
  • Climara (estradiol)
  • Delestrogen (estradiol)
  • Divigel (estradiol)
  • Duavee (estrogen/bazedoxifene)
  • Elestrin (estradiol)
  • Enjuvia (estrogen)
  • Estrace (estradiol)
  • Estraderm (estradiol)
  • Estrasorb (estradiol)
  • Estrogel (estradiol)
  • Evamist (estradiol)
  • Evista (raloxifene)
  • Femtrace (estradiol)
  • Forteo (teriparitide)
  • Fortical (calcitonin)
  • Fosamax (alendronate)
  • Fosamax Plus D (alendronate/cholecalciferol)
  • Menest (estrogen)
  • Menostar (estradiol)
  • Miacalcin (calcitonin)
  • Minivelle (estradiol)
  • Premarin (estrogen)
  • Prolia (denosumab)
  • Reclast (zoledronic acid)
  • Vivelle-Dot (estradiol)

Diagnosis Codes:

ICD-10: M80.00xA-M80.88xS, M81.0, M81.8

Related Organizations: